Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15397 total
Amentum Holdings just beat Q2 estimates on both the top and bottom line. The stock barely moved. That gap between a decent print and an unmoved price is the central tension heading into the week. Short sellers stepped…
FCHL — Fitness Champs Holdings Limited — heads into its May 14 earnings announcement having lost more than half its value in a single week and virtually all of it over the past month. The price story is stark. The…
BioAge Labs enters its May 14 Q2 earnings call with a fresh analyst initiation, a strong Q1 beat in the bank, and options traders signalling more confidence than they've shown in months. The timing of Wednesday's BTIG…
BTC enters the back half of May having pulled back modestly from a strong run — down roughly 1% on both the day and the week — but still up more than 10% over the past month. The more interesting story right now is…
WRD reported its strongest quarterly revenue growth since listing, and the numbers arrived just as short sellers were already backing away. Q1 2026 results landed this morning, and the headline was hard to dismiss.…
NIXT, the Research Affiliates Deletions ETF, heads into mid-May with a notable short interest spike that looks more structural than speculative. Short interest has more than doubled over the past month, rising 108% to…
OKLO heads into the post-earnings week with an unusual combination: a stock that has surged 47% in a month, a founder-led selling wave, shorts who are actually reducing exposure, and a newly initiated JP Morgan that…
YOOV — Concorde International Group Ltd. — heads into its May 15 earnings report having shed nearly a third of its value in a single week, with the borrow market sending contradictory signals about how confident…
Bowhead Specialty Holdings enters the week after its Q1 earnings on a strong footing — shorts are covering fast, the stock is up 11% on the week, and analysts are lifting targets. The tension is whether this rally has…
Viking Holdings heads into its Q1 earnings print — due May 14 — with a notable divergence: short interest has been quietly building while options traders have turned their most bullish in months. The options story is…
LSH heads into its May 20 earnings report carrying a striking contradiction: short sellers who spent April aggressively rebuilding positions have just as quickly begun reversing course. The past month tells the real…
PACS Group delivered one of the more striking single-week moves in the healthcare space, surging 26% after a Q1 earnings beat that forced both bulls and remaining sceptics to reprice their positions. The catalyst…
Mobile-health Network Solutions enters this week with one of the more dramatic short-positioning reversals seen in a micro-cap name this year — and the borrow market tells the story plainly. The defining feature of the…
RDDT heads into the week of May 13 with a curious split: shorts are retreating just as the founder is cashing out, and the stock fell 11% on the week despite a clean earnings beat a fortnight ago. The most striking…
Kyverna Therapeutics enters its May 27 earnings date with short sellers making their most aggressive move of the year — and the stock, paradoxically, gaining 11% on the week. Short interest has jumped 22% in a single…
GUTS just delivered its first positive earnings surprise in recent memory — and then shorts started creeping back in. Fractyl Health posted Q1 EPS of $0.06 against a consensus estimate of -$0.16, a rare beat for a…
HUT enters the week in an extraordinary position: a 33% price surge in five days, a wave of analyst upgrades still lagging the move, and a short base that has been quietly unwinding. The story this week is entirely…
JDZG enters this week as one of Nasdaq's most volatile micro-cap trades. The stock rose 77% over the past five days, closing at $2.14 — yet the borrow market tells a far more complicated story than the price action…
Vestis Corporation enters the post-earnings window having just delivered its most consequential session in over a year. Q2 adj. EPS of $0.16 doubled consensus of $0.08. Revenue of $659.4M edged past estimates. The…
ARM entered the week after a blowout earnings print facing an unusual split: almost every analyst on the Street was lifting targets sharply higher while Goldman Sachs — the lone vocal bear — raised its Sell target too,…
